AstraZeneca Earnings, Revenue beat In Q4

  • Investing.com
AstraZeneca Earnings, Revenue beat In Q4

Investing.com - AstraZeneca (LON: AZN ) reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.

AstraZeneca announced earnings per share of $1.67 on revenue of $12.01B. Analysts polled by Investing.com anticipated EPS of $1.54 on revenue of $11B.

AstraZeneca shares are up 3% from the beginning of the year and are trading at $8,624.0 , down-from-52-week-high.They are outperforming the Dow Jones which is down 1.57% from the start of the year.

AstraZeneca shares gained 3.11% in intra-day trade the report.

AstraZeneca follows other major Healthcare sector earnings this month

AstraZeneca's report follows an earnings beat by GlaxoSmithKline on Wednesday, who reported EPS of $0.256 on revenue of $9.53B, compared to forecasts EPS of $0.2417 on revenue of $9.44B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100